Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$474,377
+$56,380 QoQ
Shares Held
1,310
+10.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,223
of 3,140 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Waterloo Capital, L.P. holds $23,385,515 across 8 Drug Manufacturers - General names. AMGN ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,785 | $6,294,646 | |
| 2 | ABBV |
AbbVie Inc.
|
23,335 | $5,872,019 | |
| 3 | LLY |
ELI LILLY & Co
|
4,584 | $5,498,187 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,308 | $3,509,078 | |
| 5 | PFE |
Pfizer Inc
|
28,858 | $694,900 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,856 | $567,902 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,755 | $474,406 | |
| 8 | AMGN |
Amgen Inc
This page
|
1,310 | $474,377 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $474,377 | 1,310 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $417,997 | 1,188 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $523,041 | 1,598 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $259,059 | 918 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $277,534 | 994 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $339,589 | 1,090 | Shares | Sole | 2025-05-12 | |
| 2024-09-30 | $220,713 | 685 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $230,588 | 738 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||